Communication of prognosis to patient with PSP and family

The prognosis of progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) involves a survival shorter than 10-years since symptom onset with development of marked disability. Patients will often progress to require increased assisstance with daily living activities, and symptomatic therapies with partial effectiveness that lead to experiencing decreased quality of life. Speech difficulties and swallowing problems dictate the moderate to severe stages of the disease course adding complexity to the daily care of patients with PSP and CBS. Altogether, these create a huge burden that impacts directly to the patient family and caregivers. Communicating prognosis at each timepoint of the disease is crucial for care planning and making future life decisions. In this session, we will provide clinicians with information and skills to communicate prognosis of tauopathies with an accertive and patient-centered approach.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70857_101939
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Communication of prognosis to patient with PSP and family

Blas Couto, Juan‐Camilo Vargas‐González, Indira García‐Cordero, Ignacio Flores et al.
Alzheimer s & Dementia
Parkinson's Disease Mechanisms and Treatments
article

Communication of prognosis to patient with PSP and family

Blas Couto, Juan‐Camilo Vargas‐González, Indira García‐Cordero, Ignacio Flores, Carmela M Tartaglia, Raúl Medina Rioja, Alonso Morales‐Rivero
article en

Abstract

The prognosis of progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) involves a survival shorter than 10-years since symptom onset with development of marked disability. Patients will often progress to require increased assisstance with daily living activities, and symptomatic therapies with partial effectiveness that lead to experiencing decreased quality of life. Speech difficulties and swallowing problems dictate the moderate to severe stages of the disease course adding complexity to the daily care of patients with PSP and CBS. Altogether, these create a huge burden that impacts directly to the patient family and caregivers. Communicating prognosis at each timepoint of the disease is crucial for care planning and making future life decisions. In this session, we will provide clinicians with information and skills to communicate prognosis of tauopathies with an accertive and patient-centered approach.

Alzheimer s & DementiaVol. 21(S3)
University Health Network (CA), University of Toronto (CA), Toronto Western Hospital (CA), University of San Andrés (AR), Instituto de Neurología Cognitiva (AR), Instituto de Neurología de Buenos Aires (AR), Instituto Nacional de Neurología y Neurocirugía (MX), Favaloro Foundation (AR)
Quality Education
Openalex Percentile: Top 31%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.